大脑干中的血管协同信号的生理和分子影响
Mina Ghobrial1, R Ariel Gomez2, Justin L Grobe1,3,4,5,6
1Department of Physiology, Medical College of Wisconsin, Milwaukee, WI.
Endocrinology
|August 22, 2025
概括
新研究揭示了脑干中的素
科学领域:
- 神经科学
- 心血管生理学
- 内分泌学
背景情况:
- 内分泌氨酸 - 血管素系统 (RAS) 调节自主神经系统 (ANS) 活动和血压 (BP).
- 大脑组织表达RAS成分,能够产生和响应血管.
- 最近的发现显示了核模糊 (NuAm) 中的蛋白表达,这是一个关键的副交感中心.
研究的目的:
- 对自主调节中的NuAm和面腹侧髓 (RVLM) 的最新研究进行审查.
- 探索NuAm通过交感和副交感途径影响血压和心率的假设.
- 突显大脑RAS激活的性别差异及其与神经性高血压的联系.
主要方法:
- 对NuAm和RVLM现有文献的审查.
- 对大脑RAS组件的研究分析.
- 对自主调节和血压控制的生理数据的检查.
主要成果:
- 在特定的NuAm神经元中发现了renin表达,挑战了传统的大脑RAS观点.
- 通过与RVLM的相互作用,NuAm可能调节BP和HR.
- 关于大脑RAS激活的性别特异性的新证据.
结论:
- 在自主监管中NuAm的作用需要进一步的研究.
- NuAm和RVLM之间的相互作用对于自主平衡至关重要.
- 大脑RAS功能障碍可能导致神经性高血压,潜在的性别特异性机制.
相关概念视频
Neural Regulation of Blood Pressure
3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
875
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
875
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Hormonal Regulation of Blood Pressure
3.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.1K
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505


